RNU6-1315P

Across TCGA pan-cancer cohorts, RNU6-1315P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RNU6-1315P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-1315P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1315P expression acts as an unfavorable survival marker, although some lineages such as HNSC and CHOL show a favorable association.

KIRC, UVM, and COAD are the cancer types where RNU6-1315P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.450	0.693	<.001	116	view →
UVM	OS	Tertile	All	0.610	0.912	<.001	114	view →
COAD	DFS	Tertile	All	0.628	0.808	<.001	108	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	90	view →
ACC	OS	Tertile	All	0.123	0.631	.004	63	view →
MESO	DFS	Tertile	III,IV	0.096	0.535	<.001	42	view →
LGG	OS	Tertile	All	0.348	0.454	.018	15	view →
HNSC	DFS	Tertile	III,IV	0.769	0.658	.036	15	view →
CHOL	OS	Median	II,III,IV	0.764	0.324	.020	13	view →
BRCA	OS	Tertile	III,IV	0.867	0.915	.043	6	view →
PAAD	OS	Tertile	II,III,IV	0.734	0.559	.048	3	view →
STAD	DFS	Quartile	IV	0.087	0.456	.002	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RNU6-1315P–KIRC (OS)

Open the KIRC breakdown →